Acadian Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.4M Buy
346,489
+107,057
+45% +$21M 0.09% 201
2026
Q1
$46.9M Buy
239,432
+48,457
+25% +$9.41M 0.07% 242
2025
Q4
$33.1M Buy
190,975
+188,181
+6,735% +$34.3M 0.05% 263
2025
Q3
$531K Hold
2,794
﹤0.01% 1200
2025
Q2
$501K Sell
2,794
-1,171
-30% -$203K ﹤0.01% 1137
2025
Q1
$669K Hold
3,965
﹤0.01% 1017
2024
Q4
$597K Hold
3,965
﹤0.01% 1041
2024
Q3
$614K Sell
3,965
-1,786
-31% -$267K ﹤0.01% 1037
2024
Q2
$786K Sell
5,751
-6,431
-53% -$881K ﹤0.01% 1071
2024
Q1
$1.62M Hold
12,182
0.01% 708
2023
Q4
$1.68M Sell
12,182
-37,371
-75% -$4.91M 0.01% 718
2023
Q3
$6.04M Hold
49,553
0.03% 386
2023
Q2
$6.96M Buy
49,553
+43,843
+768% +$6.04M 0.03% 371
2023
Q1
$806K Sell
5,710
-24,586
-81% -$3.52M ﹤0.01% 933
2022
Q4
$4.74M Buy
30,296
+10,840
+56% +$1.56M 0.02% 461
2022
Q3
$2.38M Sell
19,456
-13,819
-42% -$1.82M 0.01% 583
2022
Q2
$4.42M Sell
33,275
-86,966
-72% -$11.9M 0.02% 437
2022
Q1
$16.5M Sell
120,241
-126,798
-51% -$17.7M 0.07% 235
2021
Q4
$42.7M Sell
247,039
-110,562
-31% -$16.8M 0.16% 135
2021
Q3
$51.9M Sell
357,601
-240,618
-40% -$35.2M 0.2% 122
2021
Q2
$79M Buy
598,219
+24,153
+4% +$3.16M 0.3% 96
2021
Q1
$73.7M Buy
574,066
+108,425
+23% +$13.4M 0.29% 94
2020
Q4
$55.5M Sell
465,641
-233,400
-33% -$28.5M 0.21% 98
2020
Q3
$80M Sell
699,041
-285,092
-29% -$33.7M 0.34% 74
2020
Q2
$112M Sell
984,133
-33,482
-3% -$3.55M 0.48% 47
2020
Q1
$81.7M Buy
1,017,615
+164,909
+19% +$17.1M 0.47% 53
2019
Q4
$91.1M Buy
852,706
+35,180
+4% +$3.67M 0.41% 61
2019
Q3
$87.5M Sell
817,526
-301,193
-27% -$30.9M 0.37% 72
2019
Q2
$114M Sell
1,118,719
-294,960
-21% -$28.3M 0.55% 52
2019
Q1
$127M Sell
1,413,679
-366,724
-21% -$31.8M 0.55% 51
2018
Q4
$148M Buy
1,780,403
+136,821
+8% +$12.8M 0.73% 31
2018
Q3
$177M Sell
1,643,582
-26,927
-2% -$2.95M 0.73% 31
2018
Q2
$184M Buy
1,670,509
+113,584
+7% +$11.8M 0.79% 26
2018
Q1
$156M Buy
1,556,925
+250,958
+19% +$25.7M 0.68% 36
2017
Q4
$129M Sell
1,305,967
-108,842
-8% -$10.3M 0.56% 49
2017
Q3
$132M Sell
1,414,809
-8,714
-0.6% -$925K 0.59% 45
2017
Q2
$158M Buy
1,423,523
+66,394
+5% +$7.02M 0.72% 29
2017
Q1
$133M Buy
1,357,129
+97,298
+8% +$9.27M 0.61% 39
2016
Q4
$116M Buy
1,259,831
+83,322
+7% +$7.18M 0.56% 47
2016
Q3
$99.6M Buy
1,176,509
+449,689
+62% +$37.8M 0.49% 63
2016
Q2
$59.2M Buy
726,820
+721,239
+12,923% +$54.9M 0.3% 101
2016
Q1
$399K Buy
+5,581
New +$374K ﹤0.01% 789
2015
Q4
Sell
-9,858
Closed -$606K 1428
2015
Q3
$606K Sell
9,858
-224,274
-96% -$15.7M ﹤0.01% 755
2015
Q2
$17M Sell
234,132
-253,387
-52% -$18.7M 0.08% 215
2015
Q1
$37.5M Sell
487,519
-191,131
-28% -$13.7M 0.17% 151
2014
Q4
$45.5M Buy
678,650
+46,738
+7% +$2.95M 0.2% 134
2014
Q3
$38.3M Buy
631,912
+47,534
+8% +$2.93M 0.19% 144
2014
Q2
$34.3M Buy
584,378
+186,549
+47% +$10.9M 0.17% 156
2014
Q1
$23M Buy
397,829
+132,460
+50% +$7.1M 0.12% 165
2013
Q4
$14.2M Buy
265,369
+232,637
+711% +$13.8M 0.08% 199
2013
Q3
$2.02M Buy
32,732
+31,642
+2,903% +$1.89M 0.01% 448
2013
Q2
$66K Buy
+1,090
New +$64.9K ﹤0.01% 790

Other funds holding DGX

Acadian Asset Management's DGX Position: Q2 2026 in Review

Acadian Asset Management increased its Quest Diagnostics (DGX) stake by 45% in Q2 2026, buying an estimated $21M and bringing the position to 346,489 shares worth $73.4M. The position accounts for 0.09% of the portfolio, ranked #201.

Acadian Asset Management first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $184M in Q2 2018. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Acadian Asset Management held 346,489 shares of Quest Diagnostics worth $73.4M as of Q2 2026.
  • Acadian Asset Management bought 107,057 Quest Diagnostics shares in Q2 2026, an estimated $21M.
  • Quest Diagnostics made up 0.09% of Acadian Asset Management's portfolio in Q2 2026, its #201 holding.
  • Acadian Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Acadian Asset Management's Quest Diagnostics position peaked at $184M in Q2 2018.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.